Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol. | Synapse
Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.
The study aims to evaluate the effectiveness of therapeutic fasting in reducing musculoskeletal symptoms associated with aromatase inhibitor therapy in breast cancer patients.
Conduct a feasibility study with breast cancer patients undergoing aromatase inhibitor therapy.
Implement therapeutic fasting protocols and monitor patient symptoms.
Assess changes in musculoskeletal symptoms through standardized measures.
Potential reduction in musculoskeletal symptoms was observed.
Feasibility of implementing fasting protocols was determined.
Patient adherence and response to fasting were recorded.
Abstract
ClinicalTrials.gov.NCT06172088. Registered 14 December 2023.URL: https://clinicaltrials.gov/study/NCT06172088.